Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology.
揭示 p65 是二氢吡啶啉通过靶向蛋白质降解技术改善代谢功能障碍相关脂肪肝疾病的靶点
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1567639
Zhu Xuejing, Zhang Lei, Cui Wenqian, Wang Liangjie, Xu Fengjing, Liu Mengyuan, Chen Shuangcheng, Jiang Haowen, He Zhiying, Peng Chang, Li Jinlong
